These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30386802)

  • 1. Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy.
    Alsmman AH; Mostafa EM; Mounir A
    Med Hypothesis Discov Innov Ophthalmol; 2018; 7(3):126-132. PubMed ID: 30386802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choroidal neovascularization following argon laser photocoagulation for central serous chorioretinopathy.
    Fekih O; Mabrouk S; Zgolli MH; Bakir K; Zghal I; Nacef L
    Tunis Med; 2019 Jan; 97(1):157-162. PubMed ID: 31535710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
    Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
    Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Mineralocorticoid-Receptor Antagonists: Choroidal Parameters Changes Using OCT in Central Serous Chorioretinopathy.
    Faghihi H; Mohammadzadeh V; Nabavi A; Faghihi S; Kadivar S; Ghassemi F
    Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):726-733. PubMed ID: 31755972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
    Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A
    Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in choroidal vascularity in acute central serous chorioretinopathy.
    Rasheed MA; Goud A; Mohamed A; Vupparaboina KK; Chhablani J
    Indian J Ophthalmol; 2018 Apr; 66(4):530-534. PubMed ID: 29582814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy.
    Behnia M; Khabazkhoob M; Aliakbari S; Abadi AE; Hashemi H; Pourvahidi P
    Retina; 2013 Feb; 33(2):324-8. PubMed ID: 23314231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of half adult dose of oral Rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy.
    Khan MS; Sameen M; Lodhi AA; Ahmed M; Ahmed N; Kamal M; Junejo SA
    Pak J Med Sci; 2016; 32(5):1158-1163. PubMed ID: 27882013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy.
    Sahoo NK; Mishra SB; Iovino C; Singh SR; Munk MR; Berger L; Peiretti E; Chhablani J
    Br J Ophthalmol; 2019 Nov; 103(11):1615-1618. PubMed ID: 30602447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serous chorioretinopathy.
    Marcuson J; Riley T
    Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of altering the regime of oral rifampicin therapy in the treatment of persistent central serous chorioretinopathy.
    Loya H; Ghoghari H; Rizvi SF; Khan A
    Pak J Med Sci; 2019; 35(6):1687-1690. PubMed ID: 31777516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Treatment of Central Serous Chorioretinopathy Patients Using Propranolol Tablets.
    Chen LC; Ma JW; Shieh PC; Horng CT
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK; Chang CK; Peng CH
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aspirin as treatment for central serous chorioretinopathy.
    Caccavale A; Romanazzi F; Imparato M; Negri A; Morano A; Ferentini F
    Clin Ophthalmol; 2010 Aug; 4():899-903. PubMed ID: 20714368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthreshold Continuous Wave Autofluorescence-controlled Laser Treatment of Chronic Central Serous Chorioretinopathy.
    Ashraf H; Jamshidian M; Khalili MR; Zare M; Shamsi A
    J Ophthalmic Vis Res; 2018; 13(3):236-240. PubMed ID: 30090178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
    Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M
    J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.
    Wu ZH; Lai RY; Yip YW; Chan WM; Lam DS; Lai TY
    Retina; 2011; 31(7):1378-86. PubMed ID: 21836413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argon laser treatment of central serous chorioretinopathy.
    Landers MB; Shaw HE; Anderson WB; Sinyai AJ
    Ann Ophthalmol; 1977 Dec; 9(12):1567-72. PubMed ID: 564655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM; Ruiz-Moreno JM; Gomez-Ulla F; Montero JA; Gregório T; Cachulo ML; Pires IA; Cunha-Vaz JG; Murta JN
    Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.